VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Vanda Pharmaceuticals Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.09+0.06 (+1.49%)
Close on Oct 19, 2026
- Market cap
- $246.33M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
82.2%
50M of 60M shares
Institutional holders
172
28 new, 25 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 6 sales
Net sold $2.82M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,699,280 | 8.10% | 13G (passive) amendment | Jan 31, 2025 |
| Millennium Group Management LLC | 4,260,038 | 7.00% | 13G (passive) amendment | Sep 30, 2026 |
| Renaissance Technologies LLC | 3,681,125 | 6.40% | 13G (passive) amendment | Dec 29, 2023 |
| AQR Capital Management Holdings, LLC | 3,497,695 | 5.82% | 13G (passive) | Jun 30, 2026 |
| State Street Corporation | 3,015,562 | 5.10% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VNDA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,653,737 | 12.66% | $46.84M | +377,749 | 0.00% |
| State Street Corp | 3,516,405 | 5.82% | $21.52M | +500,843 | 0.00% |
| Aqr Capital Management LLC | 3,497,695 | 5.78% | $21.41M | +1,894,119 | 0.01% |
| Renaissance Technologies LLC | 3,441,361 | 5.69% | $21.06M | −318,198 | 0.03% |
| Vanguard Capital Management LLC | 2,524,040 | 4.17% | $15.45M | +42,549 | 0.00% |
| AIGH Capital Management LLC | 2,044,169 | 3.38% | $12.51M | −705,831 | 0.79% |
| Acadian Asset Management LLC | 1,918,063 | 3.17% | $11.73K | +122,471 | 0.01% |
| Dimensional Fund Advisors LP | 1,727,349 | 2.86% | $10.57M | −44,244 | 0.00% |
| Millennium Management LLC | 1,602,813 | 2.65% | $9.81M | −278,188 | 0.00% |
| Geode Capital Management, LLC | 1,483,787 | 2.45% | $9.08M | +40,822 | 0.00% |
| Two Sigma Investments, LP | 1,349,072 | 2.23% | $8.26M | −49,129 | 0.01% |
| Marshall Wace, Llp | 1,225,996 | 2.03% | $7.50M | +629,994 | 0.01% |
| Jacobs Levy Equity Management, Inc | 1,213,326 | 2.01% | $7.43M | +44,645 | 0.03% |
| Krensavage Asset Management, LLC | 1,180,388 | 1.95% | $7.22K | – | 2.74% |
| Vanguard Portfolio Management LLC | 1,131,034 | 1.87% | $6.92M | +116,512 | 0.00% |
| Goldman Sachs Group Inc | 1,036,260 | 1.71% | $6.34M | +198,027 | 0.00% |
| Citadel Advisors LLC | 758,302 | 1.25% | $4.64M | +124,948 | 0.00% |
| Qube Research & Technologies Ltd | 729,212 | 1.21% | $4.46M | New | 0.00% |
| Federated Hermes, Inc. | 714,278 | 1.18% | $4.37M | +138,889 | 0.01% |
| Charles Schwab Investment Management Inc | 646,256 | 1.07% | $3.96M | +94,486 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 172 | 50M | 82.2% | 28 / 68 | 55 / 25 | 8M | 4M |
| Q1 2026 | 171 | 46M | 76.5% | 50 / 62 | 40 / 29 | 14M | 6M |
| Q4 2025 | 153 | 42M | 69.4% | 28 / 40 | 64 / 23 | 6M | 9M |
| Q3 2025 | 150 | 45M | 74.6% | 24 / 50 | 51 / 13 | 4M | 4M |
| Q2 2025 | 139 | 45M | 74.5% | 21 / 47 | 46 / 28 | 5M | 4M |
| Q1 2025 | 146 | 44M | 72.8% | 20 / 46 | 53 / 18 | 4M | 4M |
| Q4 2024 | 146 | 43M | 71.5% | 21 / 53 | 44 / 25 | 4M | 5M |
| Q3 2024 | 152 | 44M | 73.0% | 26 / 46 | 53 / 20 | 12M | 5M |
| Q2 2024 | 148 | 45M | 74.9% | 38 / 43 | 47 / 34 | 8M | 14M |
| Q1 2024 | 144 | 52M | 85.4% | 19 / 46 | 59 / 32 | 7M | 10M |
| Q4 2023 | 157 | 54M | 89.2% | 26 / 54 | 55 / 47 | 10M | 9M |
| Q3 2023 | 179 | 52M | 86.5% | 28 / 64 | 66 / 35 | 12M | 15M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of VNDA | Value | % of fund | As of |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 2,291,699 | 3.79% | $14.03M | 0.13% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,761,840 | 2.91% | $10.78M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,403,798 | 2.32% | $8.59M | 0.01% | Jun 30, 2026 |
| Federated Hermes MDT Small Cap Core Fund | 1,080,147 | 1.79% | $5.51M | 0.25% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 703,761 | 1.16% | $4.31M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 585,865 | 0.97% | $2.99M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 516,485 | 0.85% | $3.16M | 0.02% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 489,961 | 0.81% | $3.16M | 0.06% | May 29, 2026 |
| iShares Biotechnology ETF | 402,512 | 0.67% | $2.46M | 0.03% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 333,667 | 0.55% | $1.70M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 310,605 | 0.51% | $2.00M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 286,177 | 0.47% | $1.85M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 285,556 | 0.47% | $1.84M | 0.01% | May 31, 2026 |
| U.S. Small Cap Portfolio | 268,928 | 0.44% | $1.37M | 0.01% | Jul 31, 2026 |
| Vanguard U.S. Momentum Factor ETF | 256,365 | 0.42% | $1.65M | 0.09% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mihael Hristos Polymeropoulos | President and CEO, Director | 2,704,496 | 4.47% | Mar 4, 2026 |
| Daniel Patrick McGuire | SVP, GC and Secretary | 109,982 | 0.18% | Jun 8, 2026 |
| Scott Laverne Howell | VP and Chief People Officer | 109,620 | 0.18% | Apr 13, 2026 |
| Christos Vasilios Mihael Polymeropoulos | Senior VP, Medical Director | 129,791 | 0.21% | Apr 13, 2026 |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | 333,469 | 0.55% | Mar 4, 2026 |
| Timothy Williams | SVP & General Counsel | 377,450 | 0.62% | Mar 4, 2026 |
| Kevin Patrick Moran | SVP, CFO & Treasurer | 412,015 | 0.68% | Mar 4, 2026 |
| Gunther Birznieks | SVP, Business Development | 494,197 | 0.82% | Mar 4, 2026 |
| Richard W. Dugan | Director | 219,054 | 0.36% | Jun 8, 2026 |
| Phaedra Chrousos | Director | 164,950 | 0.27% | Jun 8, 2026 |
| Anne Sempowski Ward | Director | 160,667 | 0.27% | Jun 8, 2026 |
| Stephen Ray Mitchell | Director | 112,846 | 0.19% | Jun 8, 2026 |
| Tage Honore | Director | 135,069 | 0.22% | Jun 8, 2026 |
| Charles Cliff Duncan | Director | 98,701 | 0.16% | Jun 8, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen Ray Mitchell Director | Jun 4, 2026 | Award | +41,600 | – | – | 112,846 |
| Daniel Patrick McGuire SVP, GC and Secretary | Jun 4, 2026 | Award | +80,000 | – | – | 109,982 |
| Tage Honore Director | Jun 4, 2026 | Award | +41,600 | – | – | 135,069 |
| Anne Sempowski Ward Director | Jun 4, 2026 | Award | +41,600 | – | – | 160,667 |
| Richard W. Dugan Director | Jun 4, 2026 | Award | +41,600 | – | – | 219,054 |
| Charles Cliff Duncan Director | Jun 4, 2026 | Award | +41,600 | – | – | 98,701 |
| Phaedra Chrousos Director | Jun 4, 2026 | Award | +41,600 | – | – | 164,950 |
| Stephen Ray Mitchell Director | May 18, 2026 | Gift | −25,836 | – | – | 71,246 |
| Charles Cliff Duncan Director | Apr 22, 2026 | Award | +57,101 | – | – | 57,101 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Mar 2, 2026 | Sale | −42,442 | $8.27 | $351.00K | 411,380 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 2, 2026 | Sale | −156,235 | $8.17 | $1.28M | 2,704,496 |
| Gunther Birznieks SVP, Business Development | Mar 2, 2026 | Sale | −42,431 | $8.27 | $350.90K | 494,197 |
| Timothy Williams SVP & General Counsel | Mar 2, 2026 | Sale | −42,434 | $8.27 | $350.93K | 377,450 |
| Joakim Wijkstrom SVP, Chief Marketing Officer | Mar 2, 2026 | Sale | −30,800 | $8.27 | $254.72K | 333,469 |
| Tage Honore Director | Feb 23, 2026 | Sale | −30,000 | $8.03 | $240.90K | 93,469 |
| Timothy Williams SVP & General Counsel | Feb 18, 2026 | Award | +125,000 | – | – | 419,884 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 18, 2026 | Award | +525,000 | – | – | 2,860,731 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Feb 18, 2026 | Award | +125,000 | – | – | 453,822 |
| Gunther Birznieks SVP, Business Development | Feb 18, 2026 | Award | +125,000 | – | – | 536,628 |
| Joakim Wijkstrom SVP, Chief Marketing Officer | Feb 18, 2026 | Award | +125,000 | – | – | 364,269 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Aug 7, 2025 | Buy | +10,000 | $4.15 | $41.50K | 2,335,731 |
| Stephen Ray Mitchell Director | Jun 13, 2025 | Sale | −7,000 | $4.59 | $32.13K | 97,082 |
| Anne Sempowski Ward Director | Jun 5, 2025 | Award | +59,225 | – | – | 119,067 |
| Phaedra Chrousos Director | Jun 5, 2025 | Award | +59,225 | – | – | 123,350 |
| Tage Honore Director | Jun 5, 2025 | Award | +59,225 | – | – | 123,469 |
| Stephen Ray Mitchell Director | Jun 5, 2025 | Award | +59,225 | – | – | 104,082 |
| Richard W. Dugan Director | Jun 5, 2025 | Award | +59,225 | – | – | 177,454 |
| Mihael Hristos Polymeropoulos President and CEO, Director | May 21, 2025 | Buy | +481 | $4.39 | $2.11K | 2,325,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | May 21, 2025 | Buy | +9,519 | $4.40 | $41.88K | 2,325,250 |
| Mihael Hristos Polymeropoulos President and CEO, Director | May 16, 2025 | Buy | +20,000 | $4.22 | $84.40K | 2,315,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 6, 2025 | Buy | +5,000 | $5.02 | $25.10K | 2,290,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 6, 2025 | Buy | +5,000 | $5.01 | $25.05K | 2,295,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 5, 2025 | Buy | +5,000 | $5.03 | $25.15K | 2,285,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 5, 2025 | Buy | +5,000 | $5.01 | $25.05K | 2,280,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 3, 2025 | Buy | +10,000 | $4.71 | $47.10K | 2,275,731 |
| Joakim Wijkstrom SVP, Chief Marketing Officer | Mar 1, 2025 | Tax withholding | −15,520 | $4.76 | $73.88K | 239,269 |
| Gunther Birznieks SVP, Business Development | Mar 1, 2025 | Tax withholding | −26,941 | $4.76 | $128.24K | 411,628 |
| Timothy Williams SVP & General Counsel | Mar 1, 2025 | Tax withholding | −26,941 | $4.76 | $128.24K | 294,884 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Mar 1, 2025 | Tax withholding | −26,941 | $4.76 | $128.24K | 328,822 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Mar 1, 2025 | Tax withholding | −95,999 | $4.76 | $456.96K | 2,265,731 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 28, 2025 | Buy | +10,000 | $4.76 | $47.60K | 2,361,730 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 27, 2025 | Buy | +10,000 | $4.76 | $47.60K | 2,351,730 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 26, 2025 | Buy | +5,000 | $4.78 | $23.90K | 2,341,730 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 26, 2025 | Buy | +5,000 | $4.75 | $23.75K | 2,336,730 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 25, 2025 | Buy | +10,000 | $4.46 | $44.60K | 2,331,730 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Feb 21, 2025 | Buy | +2,000 | $4.39 | $8.78K | 355,763 |
| Gunther Birznieks SVP, Business Development | Feb 18, 2025 | Award | +125,000 | – | – | 438,569 |
| Joakim Wijkstrom SVP, Chief Marketing Officer | Feb 18, 2025 | Award | +125,000 | – | – | 254,789 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Feb 18, 2025 | Award | +125,000 | – | – | 353,763 |
| Timothy Williams SVP & General Counsel | Feb 18, 2025 | Award | +125,000 | – | – | 321,825 |
| Mihael Hristos Polymeropoulos President and CEO, Director | Feb 18, 2025 | Award | +450,000 | – | – | 2,321,730 |
| Stephen Ray Mitchell Director | Nov 14, 2024 | Sale | −5,000 | $5.17 | $25.85K | 44,857 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Jul 29, 2024 | Sale | −2,251 | $5.92 | $13.33K | 228,763 |
| Phaedra Chrousos Director | May 22, 2024 | Award | +21,887 | – | – | 64,125 |
| Richard W. Dugan Director | May 17, 2024 | Award | +20,529 | – | – | 118,229 |
| Anne Sempowski Ward Director | May 17, 2024 | Award | +20,529 | – | – | 59,842 |
| Stephen Ray Mitchell Director | May 17, 2024 | Award | +20,529 | – | – | 49,857 |
| Tage Honore Director | May 17, 2024 | Award | +20,529 | – | – | 64,244 |
| Timothy Williams SVP & General Counsel | Mar 5, 2024 | Sale | −8,941 | $4.18 | $37.37K | 196,825 |
| Kevin Patrick Moran SVP, CFO & Treasurer | Mar 5, 2024 | Sale | −8,902 | $4.20 | $37.39K | 231,014 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Moran Kevin SVP, CFO & Treasurer | Mar 2, 2026 | 42,442 | $350.82K | Mar 2, 2026 | Vesting/Settlement of Restricted Stock Units |
| H. Polymeropoulos Mihael Officer, Chairman of the Board | Mar 2, 2026 | 156,235 | $1.28M | Mar 2, 2026 | Vesting/Settlement of Restricted Stock Units |
| Wijkstrom Joakim SVP, Chief Marketing Officer | Mar 2, 2026 | 30,800 | $254.59K | Mar 2, 2026 | Vesting/Settlement of Restricted Stock Units |
| Birznieks Gunther SVP, Business Development | Mar 2, 2026 | 42,431 | $350.73K | Mar 2, 2026 | Vesting/Settlement of Restricted Stock Units |
| Williams Timothy SVP & General Counsel | Mar 2, 2026 | 42,434 | $350.76K | Mar 2, 2026 | Vesting/Settlement of Restricted Stock Units |
| Tage Honore Director | Feb 23, 2026 | 30,000 | $240.90K | Feb 23, 2026 | Vesting / Settlement of Restricted Stock Units |
| Stephen Ray Mitchell Director | Jun 13, 2025 | 7,000 | $32.16K | Jun 13, 2025 | Vesting/Settlement of Restricted Stock Units |
| Stephen Ray Mitchell Director | Nov 14, 2024 | 5,000 | $27.00K | Nov 14, 2024 | Vesting/Settlement of Restricted Stock Units |
| Kevin Patrick Moran Officer | Jul 29, 2024 | 2,251 | $13.33K | Jul 29, 2024 | Vesting/Settlement of Restricted Stock Units |
| Joakim Wijkstrom Officer | Mar 4, 2024 | 30,300 | $139.68K | Mar 4, 2024 | Vesting/Settlement of Restricted Stock Units |
| Timothy Williams Officer | Mar 4, 2024 | 32,025 | $147.64K | Mar 4, 2024 | Vesting/Settlement of Restricted Stock Units |
| Gunther Birznieks Officer | Mar 4, 2024 | 32,025 | $147.64K | Mar 4, 2024 | Vesting/Settlement of Restricted Stock Units |
| Mihael Hristos Polymeropoulos Officer, Director, Chairman of the Board | Mar 4, 2024 | 101,250 | $466.76K | Mar 4, 2024 | Vesting/Settlement of Restricted Stock Units |
| Kevin Patrick Moran Officer | Mar 4, 2024 | 27,689 | $127.65K | Mar 4, 2024 | Vesting/Settlement of Restricted Stock Units |
| Joakim Wijkstrom Officer | Aug 21, 2023 | 3,724 | $21.75K | Aug 21, 2023 | Vesting/Settlement of Restricted Stock Units |